| S. No | Product Name | Regulatory Agency | DMF No. |
| 1 | Efavirenz | USDMF | DMF #24847 |
| WHO APIMF | APIMF #173 | ||
| 2 | Capecitabine | USDMF | DMF #25054 |
| MHRA | MFD-39882-1-11433-0001 | ||
| CEP | CEP-2013-309 | ||
| JAPAN-DMF | Ref No: 5123008039364 | ||
| 3 | Imatinib mesylate (beta form) | USDMF | DMF #26322 |
| 4 | Imatinib mesylate (alpha form) | USDMF | DMF #26424 |
| EDMF | EDMF #DMFNL 03428 | ||
| CEP | CEP 2018-262 (Under review) | ||
| 5 | Dasatinib | EDMF | EDMF #DMFNL 03442 |
| 6 | Tenofovir Disoproxil Fumarate | APIMF | APIMF #219 |
| USDMF | DMF #27143 | ||
| 7 | Lopinavir | USDMF | DMF #28244 |
| 8 | Atazanavir Sulphate | APIMF | APIMF #394 |
| USDMF | DMF #28952 | ||
| 9 | Abacavir | EDMF | EDMF #3835 |
| 10 | Pemetrexed Disodium | USDMF | DMF #032639 |
| HEALTH CANADA-MF | 2019-200 | ||
| 11 | Pazopanib HCl | USDMF | DMF #033054 |
| 12 | Palbociclib | USDMF | DMF #033055 |
| HEALTH CANADA-MF | 2019-134 | ||
| 13 | Sunitinib | EDMF | Approved in EU (EDMF #03581) |
| DMF-TGA | D19-5722293/ e004718 | ||
| HEALTH CANADA-MF | 2018-202 | ||
| 14 | Erlotinib HCl | EDMF | EDMF #OGYEI/51687/2018 |
| US DMF | DMF #033226 | ||
| DMF-TGA | ERL-TGA-D196299114/n002582 |